Optithera partners in CONNECT, funded by the Terry Fox Research Institute’s Digital Health Innovation Fund

September 16, 2026

The Terry Fox Research Institute’s Digital Health & Discovery Platform (DHDP) has selected CONNECT among 14 pan-Canadian projects funded through its first Digital Health Innovation Fund. The project brings together Omnimed, Optithera and Université de Montréal.

CONNECT will build a secure “diabetes prescriptome” linking Omnimed’s real-world EMR data, Optithera’s polygenic risk scores and validated treatment guidelines. Using privacy-preserving federated learning, a large language model will help clinicians make safer, more personalized diabetes treatment decisions.

Learn more: https://www.dhdp.ca/projects/project/connect-collaborative-effort-to-optimize-diabetes-care-through-llm-enabled-clinical-decision-support

Contact us

Interested in learning more about the
OPTITHERA test?

Call us at 514-890-8247

or send us an email at
info@optithera.onmicrosoft.com

900 Saint-Denis Street, Suite R14.404
Montreal, Quebec, Canada  H2X 0A9

Alert me as soon as the Optithera test is available.

Abonnement - Anglais

Upcoming test

Polygenic risk score for cardiorenal risk in subjects with type-2 diabetes